Clinical Trial Update: PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating PD-1 monoclonal antibody with FLOT chemotherapy as neoadjuvant therapy for gastric adenocarcinoma and tumors at the esophagogastric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Adenocarcinoma
• Gastric Adenocarcinoma

Drugs mentioned

• FLOT regimen (Fluorouracil, Leucovorin, Oxaliplatin, Docetaxel)
• PD-1 monoclonal antibody

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Gastric and Esophagogastric Junction Adenocarcinoma | Phase 2 | Status: UNKNOWN